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We sought to determine which type of donor graft
provides children and young adults with the best out-
comes following liver transplantation. Using the US
Scientific Registry of Transplant Recipients database,
we identified 6467 recipients of first liver transplants
during 1989–2000 aged < 30 years. We used Cox mod-
els to examine adjusted patient and graft outcomes by
age (< 2, 2–10, 11–16, 17–29) and donor graft type (de-
ceased donor full size (DD-F), split (DD-S), living donor
(LD)].
For patients aged < 2, LD grafts had a significantly
lower risk of graft failure than DD-S (RR = 0.49,
p < 0.0001) and DD-F (RR = 0.70, p = 0.02) and lower
mortality risk than DD-S (RR = 0.71, p = 0.08) during
the first year post-transplant. In contrast, older chil-
dren exhibited a higher risk of graft loss and a trend to-
ward higher mortality associated with LD transplants.
In young adults, DD-S transplants were associated
with poor outcomes. Three-year follow up yielded sim-
ilar graft survival results but no significant differences
in mortality risk by graft type within age group.
For recipients aged < 2, LD transplants provide supe-
rior graft survival than DD-F or DD-S and trend toward
better patient survival than DD-S. Living donor is the
preferred donor source in the most common pediatric
age group (< 2 years) undergoing liver transplantation.
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Introduction
The development of transplantation of partial liver grafts in
children has been an important advance in pediatric trans-
plantation. The use of partial grafts has overcome the short-
age of full-size grafts from pediatric donors. These grafts
can come from either living donors or deceased (cadaveric)
donors. In the latter, the liver is split between an adult and
child, or a portion of a deceased donor liver is used after
size reduction (1). The use of these techniques has been re-
ported to reduce waiting list mortality for pediatric patients
(2,3). Despite the use of these techniques, the waiting list
mortality rate for the youngest pediatric patients (less than
5 years of age) remains several times higher than the adult
waiting list mortality rate (4).
For the youngest patients, the left lateral segment from an
adult liver provides adequate mass to allow survival follow-
ing transplantation. Because of the two sources for the lat-
eral segment, living donors and deceased donors, and the
availability of whole donor organs from pediatric donors,
there is controversy over which source provides the best
patient and graft survival (5–7).
Living donor transplantation offers the advantage of trans-
plantation at an earlier stage in the course of pediatric liver
disease because children then do not have to compete in
the deceased donor organ allocation system, which prior-
itizes the sickest patients first and gives some priority for
pediatric candidates. Because there appear to be advan-
tages of early transplantation in this population, the oper-
ation can be timed for optimum results (8). On the other
hand, the donor operation exposes the living donor to risks
of mortality and morbidity that would best be avoided if
there is no demonstrable recipient outcome advantage in
using this donor source.
There have been advances in the recovery of the left lat-
eral segment from deceased donor donors, such as in-
situ removal, which may improve the outcome from de-
ceased donor transplantation with these segments. Good
results have been reported after split liver transplantation,
but some studies report higher risks of graft loss when




Because of controversy regarding the use of living donor
transplantation and the importance of comparing out-
comes of the different possible procedures, we examined
national data for pediatric first liver transplants from liv-
ing donors and the two major types of deceased donor
liver transplantation: whole organ or partial (split or reduced
size).
Methods
This study used national transplant data from the Scientific Registry of Trans-
plant Recipients (SRTR). The SRTR database includes data collected by the
Organ Procurement and Transplantation Network (OPTN) and is supple-
mented by the Social Security Death Master File (SSDMF) for extra mortality
ascertainment.
The study included all primary liver transplants performed between 1989
and 2000 for recipients less than 30 years of age. Recipients of heterotopic,
multiorgan, and domino transplants were excluded. All statistical analyses
were performed using SAS 8.0 [Cary, NC: SAS Institute Inc., 1999].
One-year graft and patient survivals were analyzed using Cox regression
models. Graft failure was defined by a record of graft failure, repeat trans-
plant, or death. Patient death was ascertained by a death record in either the
OPTN or SSDMF data, with OPTN data taking priority in cases of conflicting
death dates.
For the patient survival analyses, recipients were followed until death, with
follow-up time censored at 1 year after transplant. Recipients with no record
of a death in either source were classified as alive as of the end of the 1-
year follow up. For the graft survival analyses, recipients were followed
until graft failure (including death), with follow up censored at the earliest of
last known OPTN follow up, SSDMF death date, or 1 year after transplant.
Sensitivity analyses were carried out by following patients for up to 3 years
after transplant. Additional sensitivity analyses were carried out to consider
interaction effects between center and graft type for patients less than 2
years of age.
We compared outcomes by graft source for pediatric and young adult
age groups (< 30 years) using Cox regression models fitted for 6467
recipients of first single-organ liver transplants during 1989–2000 (5142
full deceased donor [DD-F], 746 split or reduced deceased donor [DD-
S], and 579 living donor [LD]). Relative risks of mortality and graft fail-
ure were assessed by age group (< 2, 2–10, 11–16, 17–29) and or-
gan type (DD-F, DD-S, LD), adjusted for recipient race, ethnicity, sex, di-
agnosis, life support, medical urgency status at transplant, ABO com-
patibility, year of transplant, and transplant center (adjustments for the
63 centers that had performed at least 20 transplants of a graft type during
1989–2000).
Results
The distribution of liver transplants by age group and donor
source is shown in Table 1. Recipients in the 0–2-year age
group accounted for 35% of all pediatric and young adult
transplants (or 50% among ages 0–16). The most common
transplant across all young age groups used a deceased full
liver (80%). Split/partial deceased donor organs were used
Table 1: First liver transplants 1989–2000 by age group (years)
Graft type < 2 2–10 11–16 17–29 All
Full deceased donor 1438 1182 705 1817 5142
Split or reduced 454 218 57 17 746
deceased donor
Living donor 385 134 22 38 579
All transplants 2277 1534 784 1872 6467
primarily in the youngest age groups, as were living donor
transplants.
Patient and graft survival results during the first year
after transplant for each donor graft type varied dra-
matically depending on the age group of the recipient
(Figures 1 and 2). For patients 0–2 years of age, living donor
grafts had a 51% lower relative risk (RR) of graft failure than
DD-S (RR = 0.49 [ = 1.18/2.39], p < 0.0001) and 30% lower
risk of graft failure when compared with DD-F (RR = 0.70,
p = 0.02) (Figures 1 and 3). Differences in mortality risk
among the donor graft types in the 0–2 age group favored
recipients of LD grafts over DD-S (RR = 0.71, p = 0.08),
while there was no significant difference between LD and
DD-F recipient death mortality risk (RR = 0.92; p = 0.66)
(Figures 2 and 4). Recipients in the 0–2 age group had
higher risk of mortality and graft failure with DD-S livers
than DD-F livers (RR = 1.31, p = 0.04 for mortality; RR =
1.42, p < 0.001 for graft failure).
For patients aged 2–10 years, the relative risks of mortality
and graft loss were higher after LD than after DD-F (RR
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Figure 1: Relative risk of graft failure in first year by age group
and graft type. Reference group is recipients of full deceased
donor liver aged 17–29 years. Adjustments include recipient race,
ethnicity, sex, diagnosis, life support, medical urgency status at
transplant, ABO compatibility, year of transplant, and transplant
center. Within each age group, all statistically significant differ-
ences in outcomes between graft types are indicated with brack-
ets. ∗p < 0.05 for the comparison indicated; ∗∗p < 0.001 for the
comparison indicated.
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Figure 2: Relative risk of mortality in first year by age group
and graft type. Reference and adjustments as in Figure 1. Within
each age group, all statistically significant differences in outcomes
between graft types are indicated by brackets.
graft loss). Living donor transplants also tended to have
higher mortality risk than DD-S in this age group, in terms
of mortality (RR = 1.63, p = 0.10), but there was no sig-
nificant difference in the risk of graft loss (RR = 1.29, p =
0.26). In the 11–16 age group, a significantly higher relative
risk of graft failure was observed after LD than after DD-
F transplant (RR = 3.63, p = 0.0001) or DD-S transplant
(RR = 2.87, p = 0.02), although mortality risks were sim-
ilar for the three donor graft types. Among patients aged
17–29 years, the relative risk of graft failure was signifi-
cantly higher for DD-S than for DD-F livers (RR = 2.55, p
= 0.02), while the mortality risks were higher but did not
reach statistical significance (RR = 2.31, p = 0.10).
Sensitivity analyses
Similar analyses following patients for up to 3 years after
transplant supported the results found for the first year af-













Figure 3: Adjusted graft survival for recipients < 2 years by














Figure 4 : Adjusted patient survival for recipients < 2 years
by graft type. Shown for the average patient aged < 2 years in
the population.
The graft survival results were qualitatively similar, al-
though some differences no longer reached statistical sig-
nificance. Within age groups, there were no longer any sta-
tistically significant differences in mortality by graft type,
although the patterns remained similar to the first-year re-
sults.
One concern with our analysis is whether there might
be a group of experienced centers whose outcomes for
split and living donor transplants differ from those of all
other US centers. To answer this question, center by
graft type interactions were evaluated separately for the
2277 patients less than 2 years of age. Interaction terms
were included for five centers that had performed at least
20 split transplants and five that had performed at least 20
living transplants for patients aged less than 2 years during
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Figure 5: Relative risk of graft failure by age group and graft
type with patients followed for up to 3 years. Reference group
and adjustments as in Figure 1. Within each age group, all statisti-
cally significant differences in outcomes between graft types are
indicated by brackets. ∗p < 0.05 for the comparison indicated; ∗∗p
< 0.001 for the comparison indicated.
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Figure 6: Relative risk of mortality by age group and graft
type with patients followed for up to 3 years. Reference group
and adjustments as in Figure 1. There were no statistically sig-
nificant differences in outcomes between graft types within age
groups.
failure outcomes of the different graft types did not differ
significantly from the relative outcomes observed for the
remaining centers for split livers, for living livers, or overall
(p > 0.35 for all).
Discussion
There is an ongoing concern about the risk of mortality of
pediatric patients while awaiting liver transplantation. The
parents of children and the physicians caring for younger
patients are frequently challenged by the competing risks
of waiting list mortality, mortality after transplantation, and
the risk to a living donor from operation. The results of
this study should help to elucidate a strategy for this
population.
For the youngest age group, the data suggest that split liver
transplantation from deceased donors should be viewed as
the least attractive option. These grafts have a higher risk
of graft loss than the two other types of grafts and are
associated with an increased risk of post-transplant death.
Transplantation with the other two graft types offers better
outcomes.
These findings extend those previously reported from sin-
gle centers. Three authors have examined outcomes for liv-
ing vs. cadaveric transplantation in the pediatric population
(5–7). In each of these studies, living donor transplantation
was shown to have superior results to cadaveric transplan-
tation, though in each study the difference did not reach
statistical significance. In our analysis, we did not find there
to be a group of experienced centers that appeared to have
a different relative outcome in terms of graft types. While
there may be individual centers that have significantly dif-
ferent results, this does not appear to be common. If
there are centers whose survivals differ from those in this
analysis, communication with the patients’ families of the
relative outcomes of the different graft types would be
important.
There are potential limitations to this registry analysis in
that there maybe variables that influence graft choice and
outcome that are not included in these models. These vari-
ables could include issues related to the ability to undergo
live donor transplantation that may also decrease survival
after DD transplantation.
Living donor transplantation provides superior graft sur-
vival over DD-F grafts for patients younger than 2 years
old. As the current organ allocation system uses the Pe-
diatric End-stage Liver Disease (11) scoring system to pri-
oritize children for deceased donor transplantation, DD-F
grafts are more likely to be offered earlier to sicker chil-
dren, and the additional benefit of early transplantation be-
fore marked clinical deterioration may not be available. Liv-
ing donor and to some extent split transplantation may
provide access to early transplantation. Given the rela-
tive scarcity of suitably sized DD-F grafts for children and
the better outcomes associated with LD grafts, parents
should be informed of the results of LD grafts to allow
a decision regarding the risk-to-benefit ratio of living do-
nation compared with transplantation using organs from
deceased donors.
For older children, LD transplantation does not seem to
offer any benefit, as it is accompanied by a higher risk of
graft loss and a trend toward higher mortality. The reason
for this finding is not clear, though it may represent the use
of left lateral segment grafts in larger children where the
graft may be too small and the retransplant rate is higher
(12,13). In this older pediatric population, there appears
to be roughly equivalent graft survival for DD-S and DD-
F grafts. In the young adult population, transplants using
DD-S appear to do poorly.
The results observed with follow up beyond the first year
after transplantation were less significant, although in the
same direction as the findings for the first year. These addi-
tional analyses suggest that the choice of donor organ has
a great effect during the first year and that the subsequent
course is affected more by factors other than the type of
organ (DD-S, DD-F, or LD).
In summary, LD grafts in the 0–2-year age group appear
to offer the lowest risk of post-transplant graft failure and
mortality, particularly during the first year. Combined with
the expected advantages associated with earlier transplan-
tation in children and the risk of death associated with wait-
ing for transplantation, living donor transplantation should
be explored with the families of transplant candidates who
are younger than 2 years old.
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